Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrual.
De Palo G, Camerini T, Marubini E, Costa A, Formelli F, Del Vecchio M, Mariani L, Miceli R, Mascotti G, Magni A, Campa T, Di Mauro MG, Attili A, Maltoni C, Del Turco MR, Decensi A, D'Aiuto G, Veronesi U. De Palo G, et al. Among authors: formelli f. Tumori. 1997 Nov-Dec;83(6):884-94. doi: 10.1177/030089169708300603. Tumori. 1997. PMID: 9526578 Clinical Trial.
Effect of fenretinide on ovarian carcinoma occurrence.
De Palo G, Mariani L, Camerini T, Marubini E, Formelli F, Pasini B, Decensi A, Veronesi U. De Palo G, et al. Among authors: formelli f. Gynecol Oncol. 2002 Jul;86(1):24-7. doi: 10.1006/gyno.2002.6663. Gynecol Oncol. 2002. PMID: 12079295 Clinical Trial.
Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
Decensi A, Veronesi U, Miceli R, Johansson H, Mariani L, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Costa A, Perloff M, Malone WF, Formelli F. Decensi A, et al. Among authors: formelli f. Clin Cancer Res. 2003 Oct 15;9(13):4722-9. Clin Cancer Res. 2003. PMID: 14581342 Clinical Trial.
Chemoprevention of breast cancer.
De Palo G, Costa A, Formelli F, Del Vecchio M, Marubini E, Veronesi U. De Palo G, et al. Among authors: formelli f. In Vivo. 1993 Nov-Dec;7(6B):577-80. In Vivo. 1993. PMID: 8193278 Review.
Fenretinide (4-HPR) in chemoprevention of oral leukoplakia.
Chiesa F, Tradati N, Marazza M, Rossi N, Boracchi P, Mariani L, Formelli F, Giardini R, Costa A, De Palo G, et al. Chiesa F, et al. Among authors: formelli f. J Cell Biochem Suppl. 1993;17F:255-61. doi: 10.1002/jcb.240531038. J Cell Biochem Suppl. 1993. PMID: 8412202 Clinical Trial.
131 results